Boston University Alzheimer's Disease Core Center

$1,116,402P30FY2015AGNIH

Boston University Medical Campus, Boston MA

Investigators

Linked publications & trials

Paper 39677464 Paper 39643767 Paper 39454101 Paper 39379761 Paper 39291752 Paper 39291737 Paper 39254167 Paper 39231932 Paper 39207439 Paper 39173101 Paper 38980643 Paper 38958543 Paper 38958117 Paper 38949538 Paper 38942763 Paper 38915636 Paper 38883718 Paper 38721926 Paper 38712163 Paper 38641585 Paper 38460116 Paper 38441951 Paper 38426173 Paper 38425303 Paper 38423160 Paper 38418871 Paper 38317248 Paper 38244935 Paper 38194584 Paper 37840494 Paper 37808872 Paper 37718815 Paper 37592813 Paper 37580727 Paper 37528055 Paper 37491248 Paper 37474615 Paper 37322115 Paper 37260021 Paper 37245492 Paper 37212114 Paper 37212094 Paper 37057867 Paper 37051669 Paper 37038809 Paper 36997127 Paper 36970907 Paper 36946449 Paper 36840665 Paper 36795937 Paper 36722399 Paper 36710669 Paper 36681388 Paper 36648159 Paper 36628434 Paper 36621368 Paper 36617779 Paper 36577280 Paper 36565204 Paper 36564192 Paper 36530083 Paper 36482861 Paper 36394443 Paper 36324086 Paper 36314203 Paper 36308307 Paper 36305571 Paper 36264254 Paper 36253382 Paper 36251929 Paper 36220593 Paper 36189595 Paper 36178120 Paper 36097795 Paper 36093697 Paper 36062452 Paper 36031904 Paper 36031892 Paper 35996231 Paper 35894783 Paper 35871325 Paper 35842477 Paper 35797594 Paper 35768831 Paper 35725739 Paper 35699222 Paper 35640459 Paper 35585776 Paper 35567427 Paper 35551470 Paper 35545052 Paper 35531707 Paper 35513767 Paper 35444054 Paper 35439098 Paper 35418116 Paper 35413975 Paper 35379992 Paper 35354581 Paper 35351783

Abstract

The prime objective of the Boston University Alzheimer's Disease Center (BU ADC) is to provide resources to support high impact studies on the pathogenesis, detection, and treatment of Alzheimer's Disease (AD) and related disorders. The leadership team and investigators affiliated with the BU ADC represent a dynamic forward thinking team of clinicians and scientists who have made significant contributions to AD-related research and are committed to advancing the field in the years ahead. The BU ADC consists of an Administrative Core, Clinical Core, Data Management and Statistics Core, Neuropathology Core, Education and Information Transfer Core, and a Translational and Transgenic Core. The BU ADC has four aims. Aim 1 is to foster and support high-impact, innovative, state of the art research on brain aging and AD by: a) identifying, recruiting, and thoroughly characterizing subjects willing to participate in clinical trials and other cutting-edge clinical research studies; b) collecting, storing, analyzing, and distribute biological samples to support high priority AD-related research; c) conducting state-of the-art diagnostic neuropathological evaluation and maximize CNS tissue donation to support state of the art tissue-based research; and d) fostering innovative AD research through a strong pilot project program. Aim 2 is to collect and submit high quality data to the Data Management and Statistics Core for timely UDS submissions to the NACC database and for data sharing with qualified AD investigators engaged in cutting edge AD-related research while ensuring data security and integrity. Aim 3 is to support and inform the communities we serve regarding the benefits of the BU ADC and AD research and to provide a high-quality training environment for professionals at all career levels. The BU ADC has developed innovative approaches to educate medical students about AD and has pioneered methods to increase African American brain donation. Aim 4 is to breed and disseminate transgenic mouse models of AD and related disorders and to provide specialized technical services to support cutting edge translational AD-related research.

View original record on NIH RePORTER →